New research published today by the University of Southampton shows new insight into how our brain develops, which can pave the way for treating neurological disorders.
New research has shown that over-activity in a specific area of the brain is linked to certain symptoms of Schizophrenia, opening up possibilities for the development of more targeted treatments.
Can people who understand the emotions of others better interpret emotions conveyed through music? A new study by an international team of researchers suggests that abilities are linked.
A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A. Anna Ioannidou of Imperial College London, U.K., and colleagues present these findings in t
A research review into molecular insights of a licorice-derived substance called glycyrrhizin for preventing or treating cancer suggests further research could lead to specific agents for clinical use.
An international team of researchers has found that ketamine, being an NMDA receptor inhibitor, increases the brain's background noise, causing higher entropy of incoming sensory signals and disrupting their transmission between the thalamus and the cortex.
A research team at the Cluster of Excellence Physics of Life of TU Dresden and the University of California, Santa Barbara, reveals how cells sense their mechanical environment as they build tissues during embryogenesis.
Language function and the psychosocial wellbeing of patients and their families can be promoted with singing-based rehabilitation. Group intervention provides opportunities for peer support while being simultaneously cost-effective.
Recent pressure to maximize vaccine efficacy has stirred up many new discoveries within immunology, revealing numerous paradigms with untapped therapeutic potential.
The study highlights some of the warning signs of burnout and suggests that people who tend to be perfectionists are more likely to veer into burnout due to their own 'unrelenting standards'.
Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells.
Neutropenia--low levels of white blood cells called neutrophils, which fight infection--develops in more than 80 per cent of patients who receive chemotherapy for blood cancer. It occurs because chemotherapy destroys neutrophils along with tumour cells.